Therapeutic strategies for Dravet syndrome: upregulation of endogenous SCN1A and modulation of remodeling. – SCN1A-up!

Massimo MANTEGAZZA (Institut de pharmacologie moléculaire et cellulaire)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

University of Leuven
University of Tübingen
IPMC Institut de pharmacologie moléculaire et cellulaire
Ospedale San Raffaele
Radboud University

Help of the ANR 294,840 euros
Beginning and duration of the scientific project: May 2021 - 36 Months

• List of selected projects
• Permanent link to this summary on the ANR website (ANR-20-RAR4-0001)
• See the publications in the HAL-ANR portal